Atlas Venture Fund XI, L.P.'s Form 4 filing
ImageneBio, Inc. (IMA) · filed Dec 14, 2021
- Accession no.
- 0001209191-21-069644
- Filed
- Dec 14, 2021, 8:27 PM ET
- Trade date
- Mar 30-Dec 14, 2021
- Filing delay
- 259 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions. Open-market purchases total $2.00M. Open-market sales total $385.6K. It was filed 259 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Atlas Venture Fund XI, L.P.CIK 0001708269 | 10% Owner |
| Atlas Venture Opportunity Fund I, L.P.CIK 0001759241 | 10% Owner |
| Atlas Venture Associates Opportunity I, L.P.CIK 0001780065 | 10% Owner |
| Atlas Venture Associates Opportunity I, LLCCIK 0001780066 | 10% Owner |
| Atlas Venture Associates XI, LLCCIK 0001780067 | 10% Owner |
| Atlas Venture Associates XI, L.P.CIK 0001780068 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 30, 2021 | Common Stock | PPurchaseAcquired | +125,000 | $16.00 | +$2,000,000 | 874,634 | Indirect | Duplicate filing |
| Dec 10, 2021 | Common Stock | SSaleDisposed | −11,989 | $15.03F2 | −$180,194.67 | 1,256,224 | Direct | Duplicate filing |
| Dec 13, 2021 | Common Stock | SSaleDisposed | −8,330 | $14.64F4 | −$121,951.2 | 1,247,894 | Direct | Duplicate filing |
| Dec 14, 2021 | Common Stock | SSaleDisposed | −5,959 | $14.00 | −$83,426 | 1,241,935 | Direct | Duplicate filing |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.60 to $15.55 inclusive. The Reporting Persons undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (4).
Referenced by the price of 1 transaction in Table I.
- F4
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.60 to $14.65 inclusive.
Referenced by the price of 1 transaction in Table I.